Table 2.
Platelet and aggregability data of post-stroke patients and healthy controls
| Control group (n = 15) | Clopidogrel group (n = 46) | p-value | |
| PLT count upper (G/L) | 316 (218–478) | 345 (301–428) | 0.68 |
| PLT count lower (G/L) | 88 (51–124) | 71 (54–86) | 0.43 |
| PAR (%) | 58.5 (45.0–67.5) | 67.7 (61.7–72.9) | 0.15 |
| MPV (fl) upper | 10.7 (10.0–10.8) | 10.8 (10.2–11.6) | 0.30 |
| MPV (fl) lower | 10.0 (9.8–10.6) | 10.5 (9.8–11.2) | 0.47 |
| PLCR upper (%) | 28.9 (24.5–30.6) | 33.0 (26.8–38.9) | 0.14 |
| PLCR lower (%) | 25.5 (22.7–28.7) | 30.5 (24.2–36.2) | 0.14 |
| AUC | 73.5 (59.5–78.5) | 41.5 (29.0–54.0) | <0.001 |
| AUC upper | 112.5 (73.0–137) | 57.5 (33.0–79.0) | 0.003 |
| AUC lower | 23.0 (16.0–35.0) | 18.0 (14.0–23.0) | 0.26 |
PLT count upper, platelet count in the upper sample; PLT count lower, platelet count in the lower sample; PAR, platelet antisedimentation rate; AUC, area under the curve; MPV, mean platelet volume; PLCR, platelet large cell ratio. Data are presented as mean±SD as well as median (25th–75th percentiles), Mann-Whitney U test was used.